MARKET INSIGHTS
Global COVID-19 Rapid Antigen Test Kits market size was valued at USD 45.24 billion in 2024. The market is projected to decline to USD 7.27 billion by 2032, exhibiting a negative CAGR of 23.5% during the forecast period. This contraction reflects shifting demand patterns as the pandemic transitions from emergency response to endemic management.
COVID-19 Rapid Antigen Test Kits are in-vitro diagnostic devices that detect SARS-CoV-2 viral nucleoprotein antigens using immunochromatographic technology. These lateral flow assays provide qualitative results within 15-30 minutes, making them crucial tools for mass screening and point-of-care testing. The three main detection formats include fluorescence immunochromatography (84% market share), colloidal gold immunochromatography, and latex immunochromatography.
While the market faces significant contraction, certain segments maintain relevance. Hospital applications dominate with 69% market share, as healthcare systems continue using antigen tests for rapid patient triage. Europe remains the largest regional market (48% share), though declining vaccination rates and reduced testing mandates are impacting volumes. The competitive landscape features established players like Abbott and Roche, with the top five manufacturers controlling 47% of global supply.
MARKET DYNAMICS
MARKET DRIVERS
Global Demand for Fast and Accurate COVID-19 Detection Fuels Market Expansion
The urgent need for rapid COVID-19 diagnosis continues to drive substantial demand for antigen test kits worldwide. These tests provide results in as little as 15-30 minutes, compared to 24-48 hours for PCR tests, making them indispensable for mass screening and outbreak control. Recent estimates indicate that over 3 billion rapid antigen tests were administered globally in 2023 alone. The convenience factor is particularly crucial in workplace screening programs, travel requirements, and community testing initiatives where time-sensitive decisions are paramount.
Government Initiatives and Public Health Policies Accelerate Adoption
Strategic government interventions continue to significantly influence market dynamics. Many countries have implemented policies mandating regular testing in high-risk settings like schools, healthcare facilities, and long-term care homes. The European Union alone allocated more than €9 billion for COVID-19 testing infrastructure in 2022-2023, with a substantial portion dedicated to rapid antigen tests. These initiatives not only maintain steady demand but also encourage technological improvements in test accuracy and usability.
Furthermore, the increasing shift toward decentralized testing models, where individuals self-test at home rather than visiting healthcare facilities, has created new demand streams. This is evidenced by the over 65% year-over-year growth in the home testing segment during 2023.
MARKET RESTRAINTS
Decreasing Pandemic Urgency and Testing Fatigue Challenge Market Growth
While essential during the pandemic's peak, declining COVID-19 case numbers and reduced public health emergencies have decreased the perceived need for frequent testing. Global testing volumes dropped by nearly 40% in 2023 compared to 2022, reflecting changing priorities as the virus becomes endemic. Many governments have scaled back free testing programs, shifting costs to consumers and potentially limiting adoption rates in price-sensitive markets.
Accuracy Concerns in Asymptomatic Cases Impact Consumer Confidence
While rapid antigen tests deliver excellent specificity (often exceeding 98%), their sensitivity—particularly in asymptomatic cases—remains a challenge. Recent studies show sensitivity rates between 60-80% for asymptomatic infections compared to PCR testing. This performance gap, combined with the emergence of new variants, creates hesitation among both consumers and healthcare providers regarding test reliability, especially in low-prevalence settings where false positives become more likely.
MARKET CHALLENGES
Logistical Complexities in Global Supply Chains Disrupt Market Stability
The rapid antigen test market faces ongoing supply chain vulnerabilities, from raw material shortages to distribution bottlenecks. Key components like nitrocellulose membranes and gold nanoparticles experienced price fluctuations exceeding 25% in 2023 due to supply-demand imbalances. These challenges are particularly acute for manufacturers trying to maintain inventory levels amid unpredictable demand patterns as pandemic waves emerge and subside.
Regulatory Hurdles and Quality Control Issues
Differing regulatory standards across regions create barriers to market entry and expansion. While the EU maintains a centralized review system through the European Medicines Agency, other markets like the U.S. require separate FDA emergency use authorizations. These complex approval processes can delay product launches by 3-6 months, potentially causing companies to miss critical demand windows.
Consumer Education and Misinformation
Persistent public confusion about appropriate test usage—including timing, interpretation, and limitations—reduces effectiveness. Surveys indicate that nearly 45% of consumers remain unaware of the optimal testing window post-exposure, leading to improper use and diminished confidence in results.
MARKET OPPORTUNITIES
Technological Innovations Create New Growth Pathways
Emerging technologies present significant opportunities for market participants. Multiplex testing platforms capable of detecting COVID-19 alongside influenza and RSV are gaining traction, with several major manufacturers launching combo tests in 2023. Digital connectivity features, including smartphone-based result interpretation and reporting, are becoming standard among premium products. These value-added capabilities justify higher price points and create differentiation in an increasingly competitive market.
Additionally, advancements in shelf-stable formulations and ambient temperature storage are expanding market access to resource-limited settings. Tests requiring no refrigeration have seen adoption rates increase by over 120% in tropical regions since 2022.
Strategic Partnerships Strengthen Market Position
Collaborations between diagnostics companies and retail/distribution networks are creating new access channels. Major pharmacy chains now account for over 30% of test kit sales in developed markets, compared to just 12% in 2021. These partnerships combine manufacturing expertise with extensive consumer reach, ensuring product availability while reducing inventory risks through just-in-time delivery models.
Segment Analysis:
By Type
Fluorescence Immunochromatography Dominates Due to High Accuracy and Rapid Results
The market is segmented based on technology type into:
-
Fluorescence Immunochromatography
-
Colloidal Gold Immunochromatography
-
Latex Immunochromatography
-
Others
By Application
Hospital Segment Leads Due to Widespread Clinical Adoption and Regulatory Approvals
The market is segmented based on application into:
By Distribution Channel
Retail Pharmacies Segment Grows Due to Increased Consumer Accessibility
The market is segmented based on distribution channel into:
-
Online Platforms
-
Retail Pharmacies
-
Hospital Pharmacies
-
Direct Sales
By End User
Diagnostic Laboratories Segment Expands with Growing Testing Volumes
The market is segmented based on end user into:
-
Diagnostic Laboratories
-
Research Institutes
-
Government Organizations
-
Individuals
COMPETITIVE LANDSCAPE
Key Industry Players
Market Leaders Focus on Innovation & Scalability Amid Declining Demand
The global COVID-19 rapid antigen test kits market features a dynamic competitive environment dominated by diagnostic giants and specialized biotech firms. Abbott Laboratories maintains a strong market position, holding approximately 15% revenue share in 2024, driven by its Panbioâ„¢ COVID-19 Ag Rapid Test which accounts for 60% of its diagnostic portfolio in Europe. The company's established distribution network across 130 countries provides significant competitive advantage.
Roche Diagnostics and QuidelOrtho collectively capture nearly 22% market share, leveraging their expertise in immunochromatographic assays. Roche's SARS-CoV-2 Rapid Antigen Test achieved CE marking in 2023, enhancing its European market penetration where antigen testing remains prevalent in healthcare settings.
The market has witnessed strategic shifts as demand declines post-pandemic, with companies like SD Biosensor pivoting towards multiplex testing platforms combining COVID-19 with influenza detection. Meanwhile, Asian manufacturers including Wondfo Biotech and ACON Laboratories are gaining traction through competitive pricing, controlling 31% of the global production capacity as of Q1 2024.
Emerging players face challenges as the market contracts at -23.5% CAGR, forcing consolidation. Recent M&A activity saw Danaher Corporation acquire three mid-sized test kit manufacturers to expand its point-of-care diagnostics vertical. Regulatory hurdles in emerging markets continue to impact smaller participants, with 17% of regional manufacturers exiting the space since 2023.
List of Key COVID-19 Rapid Antigen Test Kit Manufacturers
COVID-19 RAPID ANTIGEN TEST KITS MARKET TRENDS
Shift Towards At-Home Testing Spurs Market Adaptation
The COVID-19 rapid antigen test kits market has witnessed a paradigm shift towards decentralized testing models, with at-home self-testing kits gaining widespread adoption. Regulatory approvals for over-the-counter test kits in major markets have facilitated this transition. In 2022 alone, the home testing segment accounted for approximately 17% of total rapid antigen test sales, representing a threefold increase from 2021 levels. This trend persists as consumers prioritize convenience and immediate results, particularly in regions experiencing cyclical infection waves. Manufacturers are responding with user-friendly designs featuring color-coded results and smartphone integration for digital verification.
Other Trends
Technological Advancements in Test Sensitivity
The rapid antigen test market has seen meaningful improvements in analytical sensitivity, with next-generation assays now achieving 90-95% specificity compared to 80-85% in early pandemic versions. This enhancement addresses previous concerns about false negatives, particularly in asymptomatic cases. Recent product innovations utilize nanoparticle conjugation and fluorescence-based detection to improve low viral load detection. Several manufacturers have achieved EUA approvals for tests detecting emerging variants, though this remains an ongoing challenge as SARS-CoV-2 continues to evolve.
Supply Chain Optimization and Localized Production
Geopolitical disruptions have accelerated regional manufacturing strategies across the industry. While Europe remains the dominant market (48% share in 2024), Asia-Pacific has emerged as the fastest-growing production hub with a 34% increase in localized manufacturing capacity since 2022. This mirrors broader healthcare supply chain diversification trends, with companies establishing redundant production lines to mitigate raw material shortages. The average lead time for test kit components has decreased from 12 weeks in 2021 to 5 weeks currently, reflecting improved inventory management practices industry-wide.
Regional Analysis: COVID-19 Rapid Antigen Test Kits Market
North America
The North American market remains a key adopter of rapid antigen test kits, driven by stringent regulatory approvals from the FDA and sustained demand from healthcare providers. The U.S. dominates with over 60% of regional revenue, supported by government stockpiling initiatives and widespread use in workplaces and schools. Fluorescence immunochromatography-based tests lead the market due to higher accuracy, while home-testing adoption grows steadily. However, declining COVID-19 case numbers have slowed bulk procurement, shifting focus toward Omicron-specific test iterations. Challenges include pricing pressures from generic test kit manufacturers.
Europe
Europe holds the largest global market share (48%), with Germany and France as primary consumers. The EU's unified procurement strategy during the pandemic ensured consistent demand, though post-emergency phase needs now revolve around periodic replenishment. Strict CE-IVD certification requirements create barriers for new entrants, reinforcing the dominance of established players like Roche and Siemens. While hospitals remain the primary end-users, community testing centers continue contributing to volume sales. Market saturation is becoming evident, prompting manufacturers to diversify into multiplex respiratory panels combining COVID-19 with flu detection.
Asia-Pacific
This high-growth region is powered by China's massive production capacity and India's price-sensitive demand. Local manufacturers like Wondfo and Mylab have gained traction through cost advantages, though concerns persist about quality consistency. Governments across Southeast Asia maintain strategic reserves, creating stable offtake channels despite fluctuating case numbers. Two distinct trends emerge: Tier-1 cities prefer advanced fluorescence tests, while rural areas rely on affordable colloidal gold kits. Japan and South Korea exhibit strong innovation in digital-reader integrated tests, setting regional benchmarks for home-testing convenience.
South America
Market development remains uneven, with Brazil accounting for nearly 70% of regional sales. Economic constraints limit adoption rates, forcing reliance on donated test kits from global health organizations. Temperature control issues during distribution affect test efficacy in tropical climates, creating demand for heat-stable formulations. While antigen testing penetration improved during pandemic peaks, many countries now revert to prioritized PCR testing for official case confirmation. Nonetheless, Brazil's ANVISA continues approving new kits, fostering competition among multinational and domestic suppliers.
Middle East & Africa
Gulf Cooperation Council (GCC) countries drive demand through advanced healthcare infrastructure, while Sub-Saharan Africa depends largely on donor-funded programs. The UAE and Saudi Arabia have established themselves as regional distribution hubs, with tariff-free zones attracting manufacturers. Challenges include variable regulatory standards and counterfeit products entering through informal channels. South Africa leads in local manufacturing capabilities, though most nations rely on imports. Religious pilgrimage sites continue generating concentrated demand spikes, requiring specialized high-throughput testing solutions.
Report Scope
This market research report offers a holistic overview of global and regional markets for COVID-19 Rapid Antigen Test Kits for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Key Coverage Areas:
-
✅ Market Overview
-
✅ Segmentation Analysis
-
By product type or category
-
By application or usage area
-
By end-user industry
-
By distribution channel (if applicable)
-
✅ Regional Insights
-
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
-
Country-level data for key markets
-
✅ Competitive Landscape
-
Company profiles and market share analysis
-
Key strategies: M&A, partnerships, expansions
-
Product portfolio and pricing strategies
-
✅ Technology & Innovation
-
Emerging technologies and R&D trends
-
Automation, digitalization, sustainability initiatives
-
Impact of AI, IoT, or other disruptors (where applicable)
-
✅ Market Dynamics
-
Key drivers supporting market growth
-
Restraints and potential risk factors
-
Supply chain trends and challenges
-
✅ Opportunities & Recommendations
-
✅ Stakeholder Insights
-
Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers
FREQUENTLY ASKED QUESTIONS:
What is the current market size of COVID-19 Rapid Antigen Test Kits Market?
-> Global COVID-19 Rapid Antigen Test Kits market was valued at USD 45,240 million in 2024 and is projected to reach USD 7,270 million by 2032, at a CAGR of -23.5% during the forecast period.
Which key companies operate in COVID-19 Rapid Antigen Test Kits Market?
-> Key players include Abbott, Quidel, ACCESS BIO, CTK Biotech, SD Biosensor, Ellume, InBios, Celltrion, ROCHE, and BD, among others. The top five manufacturers hold a combined market share of over 47%.
What are the key growth drivers?
-> Key growth drivers include continued demand for rapid testing solutions, government healthcare initiatives, and workplace/school screening requirements, though the market is declining post-pandemic.
Which region dominates the market?
-> Europe is the largest market with 48% share, followed by North America. Asia-Pacific shows significant growth potential with increasing healthcare infrastructure development.
What are the emerging trends?
-> Emerging trends include development of multi-pathogen test kits, digital reporting integration, and increased focus on home-testing solutions with improved accuracy.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 COVID-19 Rapid Antigen Test Kits Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global COVID-19 Rapid Antigen Test Kits Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global COVID-19 Rapid Antigen Test Kits Overall Market Size
2.1 Global COVID-19 Rapid Antigen Test Kits Market Size: 2024 VS 2032
2.2 Global COVID-19 Rapid Antigen Test Kits Market Size, Prospects & Forecasts: 2020-2032
2.3 Global COVID-19 Rapid Antigen Test Kits Sales: 2020-2032
3 Company Landscape
3.1 Top COVID-19 Rapid Antigen Test Kits Players in Global Market
3.2 Top Global COVID-19 Rapid Antigen Test Kits Companies Ranked by Revenue
3.3 Global COVID-19 Rapid Antigen Test Kits Revenue by Companies
3.4 Global COVID-19 Rapid Antigen Test Kits Sales by Companies
3.5 Global COVID-19 Rapid Antigen Test Kits Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 COVID-19 Rapid Antigen Test Kits Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers COVID-19 Rapid Antigen Test Kits Product Type
3.8 Tier 1, Tier 2, and Tier 3 COVID-19 Rapid Antigen Test Kits Players in Global Market
3.8.1 List of Global Tier 1 COVID-19 Rapid Antigen Test Kits Companies
3.8.2 List of Global Tier 2 and Tier 3 COVID-19 Rapid Antigen Test Kits Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global COVID-19 Rapid Antigen Test Kits Market Size Markets, 2024 & 2032
4.1.2 Fluorescence Immunochromatography
4.1.3 Colloidal Gold Immunochromatography
4.1.4 Latex Immunochromatography
4.1.5 Others
4.2 Segment by Type - Global COVID-19 Rapid Antigen Test Kits Revenue & Forecasts
4.2.1 Segment by Type - Global COVID-19 Rapid Antigen Test Kits Revenue, 2020-2025
4.2.2 Segment by Type - Global COVID-19 Rapid Antigen Test Kits Revenue, 2026-2032
4.2.3 Segment by Type - Global COVID-19 Rapid Antigen Test Kits Revenue Market Share, 2020-2032
4.3 Segment by Type - Global COVID-19 Rapid Antigen Test Kits Sales & Forecasts
4.3.1 Segment by Type - Global COVID-19 Rapid Antigen Test Kits Sales, 2020-2025
4.3.2 Segment by Type - Global COVID-19 Rapid Antigen Test Kits Sales, 2026-2032
4.3.3 Segment by Type - Global COVID-19 Rapid Antigen Test Kits Sales Market Share, 2020-2032
4.4 Segment by Type - Global COVID-19 Rapid Antigen Test Kits Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global COVID-19 Rapid Antigen Test Kits Market Size, 2024 & 2032
5.1.2 Hospital
5.1.3 Home
5.1.4 School
5.1.5 Third-Party Detection Institution
5.1.6 Others
5.2 Segment by Application - Global COVID-19 Rapid Antigen Test Kits Revenue & Forecasts
5.2.1 Segment by Application - Global COVID-19 Rapid Antigen Test Kits Revenue, 2020-2025
5.2.2 Segment by Application - Global COVID-19 Rapid Antigen Test Kits Revenue, 2026-2032
5.2.3 Segment by Application - Global COVID-19 Rapid Antigen Test Kits Revenue Market Share, 2020-2032
5.3 Segment by Application - Global COVID-19 Rapid Antigen Test Kits Sales & Forecasts
5.3.1 Segment by Application - Global COVID-19 Rapid Antigen Test Kits Sales, 2020-2025
5.3.2 Segment by Application - Global COVID-19 Rapid Antigen Test Kits Sales, 2026-2032
5.3.3 Segment by Application - Global COVID-19 Rapid Antigen Test Kits Sales Market Share, 2020-2032
5.4 Segment by Application - Global COVID-19 Rapid Antigen Test Kits Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global COVID-19 Rapid Antigen Test Kits Market Size, 2024 & 2032
6.2 By Region - Global COVID-19 Rapid Antigen Test Kits Revenue & Forecasts
6.2.1 By Region - Global COVID-19 Rapid Antigen Test Kits Revenue, 2020-2025
6.2.2 By Region - Global COVID-19 Rapid Antigen Test Kits Revenue, 2026-2032
6.2.3 By Region - Global COVID-19 Rapid Antigen Test Kits Revenue Market Share, 2020-2032
6.3 By Region - Global COVID-19 Rapid Antigen Test Kits Sales & Forecasts
6.3.1 By Region - Global COVID-19 Rapid Antigen Test Kits Sales, 2020-2025
6.3.2 By Region - Global COVID-19 Rapid Antigen Test Kits Sales, 2026-2032
6.3.3 By Region - Global COVID-19 Rapid Antigen Test Kits Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America COVID-19 Rapid Antigen Test Kits Revenue, 2020-2032
6.4.2 By Country - North America COVID-19 Rapid Antigen Test Kits Sales, 2020-2032
6.4.3 United States COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.4.4 Canada COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.4.5 Mexico COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe COVID-19 Rapid Antigen Test Kits Revenue, 2020-2032
6.5.2 By Country - Europe COVID-19 Rapid Antigen Test Kits Sales, 2020-2032
6.5.3 Germany COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.5.4 France COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.5.5 U.K. COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.5.6 Italy COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.5.7 Russia COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.5.8 Nordic Countries COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.5.9 Benelux COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia COVID-19 Rapid Antigen Test Kits Revenue, 2020-2032
6.6.2 By Region - Asia COVID-19 Rapid Antigen Test Kits Sales, 2020-2032
6.6.3 China COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.6.4 Japan COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.6.5 South Korea COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.6.6 Southeast Asia COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.6.7 India COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America COVID-19 Rapid Antigen Test Kits Revenue, 2020-2032
6.7.2 By Country - South America COVID-19 Rapid Antigen Test Kits Sales, 2020-2032
6.7.3 Brazil COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.7.4 Argentina COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa COVID-19 Rapid Antigen Test Kits Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales, 2020-2032
6.8.3 Turkey COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.8.4 Israel COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.8.5 Saudi Arabia COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
6.8.6 UAE COVID-19 Rapid Antigen Test Kits Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.1.4 Abbott COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.1.5 Abbott Key News & Latest Developments
7.2 Quidel
7.2.1 Quidel Company Summary
7.2.2 Quidel Business Overview
7.2.3 Quidel COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.2.4 Quidel COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.2.5 Quidel Key News & Latest Developments
7.3 ACCESS BIO
7.3.1 ACCESS BIO Company Summary
7.3.2 ACCESS BIO Business Overview
7.3.3 ACCESS BIO COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.3.4 ACCESS BIO COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.3.5 ACCESS BIO Key News & Latest Developments
7.4 CTK Biotech
7.4.1 CTK Biotech Company Summary
7.4.2 CTK Biotech Business Overview
7.4.3 CTK Biotech COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.4.4 CTK Biotech COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.4.5 CTK Biotech Key News & Latest Developments
7.5 SD Biosensor
7.5.1 SD Biosensor Company Summary
7.5.2 SD Biosensor Business Overview
7.5.3 SD Biosensor COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.5.4 SD Biosensor COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.5.5 SD Biosensor Key News & Latest Developments
7.6 Ellume
7.6.1 Ellume Company Summary
7.6.2 Ellume Business Overview
7.6.3 Ellume COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.6.4 Ellume COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.6.5 Ellume Key News & Latest Developments
7.7 InBios
7.7.1 InBios Company Summary
7.7.2 InBios Business Overview
7.7.3 InBios COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.7.4 InBios COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.7.5 InBios Key News & Latest Developments
7.8 Celltrion
7.8.1 Celltrion Company Summary
7.8.2 Celltrion Business Overview
7.8.3 Celltrion COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.8.4 Celltrion COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.8.5 Celltrion Key News & Latest Developments
7.9 AESKU.GROUP
7.9.1 AESKU.GROUP Company Summary
7.9.2 AESKU.GROUP Business Overview
7.9.3 AESKU.GROUP COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.9.4 AESKU.GROUP COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.9.5 AESKU.GROUP Key News & Latest Developments
7.10 ROCHE
7.10.1 ROCHE Company Summary
7.10.2 ROCHE Business Overview
7.10.3 ROCHE COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.10.4 ROCHE COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.10.5 ROCHE Key News & Latest Developments
7.11 BD
7.11.1 BD Company Summary
7.11.2 BD Business Overview
7.11.3 BD COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.11.4 BD COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.11.5 BD Key News & Latest Developments
7.12 OraSure Technologies
7.12.1 OraSure Technologies Company Summary
7.12.2 OraSure Technologies Business Overview
7.12.3 OraSure Technologies COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.12.4 OraSure Technologies COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.12.5 OraSure Technologies Key News & Latest Developments
7.13 Clip Health
7.13.1 Clip Health Company Summary
7.13.2 Clip Health Business Overview
7.13.3 Clip Health COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.13.4 Clip Health COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.13.5 Clip Health Key News & Latest Developments
7.14 LumiraDx
7.14.1 LumiraDx Company Summary
7.14.2 LumiraDx Business Overview
7.14.3 LumiraDx COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.14.4 LumiraDx COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.14.5 LumiraDx Key News & Latest Developments
7.15 Princeton BioMeditech Corporation
7.15.1 Princeton BioMeditech Corporation Company Summary
7.15.2 Princeton BioMeditech Corporation Business Overview
7.15.3 Princeton BioMeditech Corporation COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.15.4 Princeton BioMeditech Corporation COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.15.5 Princeton BioMeditech Corporation Key News & Latest Developments
7.16 RapiGEN Inc.
7.16.1 RapiGEN Inc. Company Summary
7.16.2 RapiGEN Inc. Business Overview
7.16.3 RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.16.4 RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.16.5 RapiGEN Inc. Key News & Latest Developments
7.17 Orient Gene
7.17.1 Orient Gene Company Summary
7.17.2 Orient Gene Business Overview
7.17.3 Orient Gene COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.17.4 Orient Gene COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.17.5 Orient Gene Key News & Latest Developments
7.18 Wondfo Biotech
7.18.1 Wondfo Biotech Company Summary
7.18.2 Wondfo Biotech Business Overview
7.18.3 Wondfo Biotech COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.18.4 Wondfo Biotech COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.18.5 Wondfo Biotech Key News & Latest Developments
7.19 Ihealth (Andon Health)
7.19.1 Ihealth (Andon Health) Company Summary
7.19.2 Ihealth (Andon Health) Business Overview
7.19.3 Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.19.4 Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.19.5 Ihealth (Andon Health) Key News & Latest Developments
7.20 Wantai BioPharm
7.20.1 Wantai BioPharm Company Summary
7.20.2 Wantai BioPharm Business Overview
7.20.3 Wantai BioPharm COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.20.4 Wantai BioPharm COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.20.5 Wantai BioPharm Key News & Latest Developments
7.21 Biotest Biotech
7.21.1 Biotest Biotech Company Summary
7.21.2 Biotest Biotech Business Overview
7.21.3 Biotest Biotech COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.21.4 Biotest Biotech COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.21.5 Biotest Biotech Key News & Latest Developments
7.22 Shenzhen YHLO Biotech
7.22.1 Shenzhen YHLO Biotech Company Summary
7.22.2 Shenzhen YHLO Biotech Business Overview
7.22.3 Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.22.4 Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.22.5 Shenzhen YHLO Biotech Key News & Latest Developments
7.23 Vazyme Biotech
7.23.1 Vazyme Biotech Company Summary
7.23.2 Vazyme Biotech Business Overview
7.23.3 Vazyme Biotech COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.23.4 Vazyme Biotech COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.23.5 Vazyme Biotech Key News & Latest Developments
7.24 EasyDiagnosis Biomedicine
7.24.1 EasyDiagnosis Biomedicine Company Summary
7.24.2 EasyDiagnosis Biomedicine Business Overview
7.24.3 EasyDiagnosis Biomedicine COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.24.4 EasyDiagnosis Biomedicine COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.24.5 EasyDiagnosis Biomedicine Key News & Latest Developments
7.25 Beijing Hotgen Biotech
7.25.1 Beijing Hotgen Biotech Company Summary
7.25.2 Beijing Hotgen Biotech Business Overview
7.25.3 Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.25.4 Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.25.5 Beijing Hotgen Biotech Key News & Latest Developments
7.26 Assure Tech
7.26.1 Assure Tech Company Summary
7.26.2 Assure Tech Business Overview
7.26.3 Assure Tech COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.26.4 Assure Tech COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.26.5 Assure Tech Key News & Latest Developments
7.27 Hangzhou AllTest Biotech
7.27.1 Hangzhou AllTest Biotech Company Summary
7.27.2 Hangzhou AllTest Biotech Business Overview
7.27.3 Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.27.4 Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.27.5 Hangzhou AllTest Biotech Key News & Latest Developments
7.28 ACON Biotech
7.28.1 ACON Biotech Company Summary
7.28.2 ACON Biotech Business Overview
7.28.3 ACON Biotech COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.28.4 ACON Biotech COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.28.5 ACON Biotech Key News & Latest Developments
7.29 BGI Genomics
7.29.1 BGI Genomics Company Summary
7.29.2 BGI Genomics Business Overview
7.29.3 BGI Genomics COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.29.4 BGI Genomics COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.29.5 BGI Genomics Key News & Latest Developments
7.30 Lepu Medical Technology
7.30.1 Lepu Medical Technology Company Summary
7.30.2 Lepu Medical Technology Business Overview
7.30.3 Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.30.4 Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.30.5 Lepu Medical Technology Key News & Latest Developments
7.31 Jinwofu Bioengineering Technology
7.31.1 Jinwofu Bioengineering Technology Company Summary
7.31.2 Jinwofu Bioengineering Technology Business Overview
7.31.3 Jinwofu Bioengineering Technology COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.31.4 Jinwofu Bioengineering Technology COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.31.5 Jinwofu Bioengineering Technology Key News & Latest Developments
7.32 Phase Scientific
7.32.1 Phase Scientific Company Summary
7.32.2 Phase Scientific Business Overview
7.32.3 Phase Scientific COVID-19 Rapid Antigen Test Kits Major Product Offerings
7.32.4 Phase Scientific COVID-19 Rapid Antigen Test Kits Sales and Revenue in Global (2020-2025)
7.32.5 Phase Scientific Key News & Latest Developments
8 Global COVID-19 Rapid Antigen Test Kits Production Capacity, Analysis
8.1 Global COVID-19 Rapid Antigen Test Kits Production Capacity, 2020-2032
8.2 COVID-19 Rapid Antigen Test Kits Production Capacity of Key Manufacturers in Global Market
8.3 Global COVID-19 Rapid Antigen Test Kits Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 COVID-19 Rapid Antigen Test Kits Supply Chain Analysis
10.1 COVID-19 Rapid Antigen Test Kits Industry Value Chain
10.2 COVID-19 Rapid Antigen Test Kits Upstream Market
10.3 COVID-19 Rapid Antigen Test Kits Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 COVID-19 Rapid Antigen Test Kits Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of COVID-19 Rapid Antigen Test Kits in Global Market
Table 2. Top COVID-19 Rapid Antigen Test Kits Players in Global Market, Ranking by Revenue (2024)
Table 3. Global COVID-19 Rapid Antigen Test Kits Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global COVID-19 Rapid Antigen Test Kits Revenue Share by Companies, 2020-2025
Table 5. Global COVID-19 Rapid Antigen Test Kits Sales by Companies, (M Units), 2020-2025
Table 6. Global COVID-19 Rapid Antigen Test Kits Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers COVID-19 Rapid Antigen Test Kits Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers COVID-19 Rapid Antigen Test Kits Product Type
Table 9. List of Global Tier 1 COVID-19 Rapid Antigen Test Kits Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 COVID-19 Rapid Antigen Test Kits Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global COVID-19 Rapid Antigen Test Kits Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global COVID-19 Rapid Antigen Test Kits Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global COVID-19 Rapid Antigen Test Kits Sales (M Units), 2020-2025
Table 15. Segment by Type - Global COVID-19 Rapid Antigen Test Kits Sales (M Units), 2026-2032
Table 16. Segment by Application – Global COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2020-2025
Table 20. Segment by Application - Global COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2026-2032
Table 21. By Region – Global COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2020-2025
Table 25. By Region - Global COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2026-2032
Table 26. By Country - North America COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2020-2025
Table 29. By Country - North America COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2026-2032
Table 30. By Country - Europe COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2020-2025
Table 33. By Country - Europe COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2026-2032
Table 34. By Region - Asia COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2020-2025
Table 37. By Region - Asia COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2026-2032
Table 38. By Country - South America COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2020-2025
Table 41. By Country - South America COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2026-2032
Table 42. By Country - Middle East & Africa COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2020-2025
Table 45. By Country - Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales, (M Units), 2026-2032
Table 46. Abbott Company Summary
Table 47. Abbott COVID-19 Rapid Antigen Test Kits Product Offerings
Table 48. Abbott COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Abbott Key News & Latest Developments
Table 50. Quidel Company Summary
Table 51. Quidel COVID-19 Rapid Antigen Test Kits Product Offerings
Table 52. Quidel COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Quidel Key News & Latest Developments
Table 54. ACCESS BIO Company Summary
Table 55. ACCESS BIO COVID-19 Rapid Antigen Test Kits Product Offerings
Table 56. ACCESS BIO COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. ACCESS BIO Key News & Latest Developments
Table 58. CTK Biotech Company Summary
Table 59. CTK Biotech COVID-19 Rapid Antigen Test Kits Product Offerings
Table 60. CTK Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. CTK Biotech Key News & Latest Developments
Table 62. SD Biosensor Company Summary
Table 63. SD Biosensor COVID-19 Rapid Antigen Test Kits Product Offerings
Table 64. SD Biosensor COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. SD Biosensor Key News & Latest Developments
Table 66. Ellume Company Summary
Table 67. Ellume COVID-19 Rapid Antigen Test Kits Product Offerings
Table 68. Ellume COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Ellume Key News & Latest Developments
Table 70. InBios Company Summary
Table 71. InBios COVID-19 Rapid Antigen Test Kits Product Offerings
Table 72. InBios COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. InBios Key News & Latest Developments
Table 74. Celltrion Company Summary
Table 75. Celltrion COVID-19 Rapid Antigen Test Kits Product Offerings
Table 76. Celltrion COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Celltrion Key News & Latest Developments
Table 78. AESKU.GROUP Company Summary
Table 79. AESKU.GROUP COVID-19 Rapid Antigen Test Kits Product Offerings
Table 80. AESKU.GROUP COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. AESKU.GROUP Key News & Latest Developments
Table 82. ROCHE Company Summary
Table 83. ROCHE COVID-19 Rapid Antigen Test Kits Product Offerings
Table 84. ROCHE COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. ROCHE Key News & Latest Developments
Table 86. BD Company Summary
Table 87. BD COVID-19 Rapid Antigen Test Kits Product Offerings
Table 88. BD COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. BD Key News & Latest Developments
Table 90. OraSure Technologies Company Summary
Table 91. OraSure Technologies COVID-19 Rapid Antigen Test Kits Product Offerings
Table 92. OraSure Technologies COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. OraSure Technologies Key News & Latest Developments
Table 94. Clip Health Company Summary
Table 95. Clip Health COVID-19 Rapid Antigen Test Kits Product Offerings
Table 96. Clip Health COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Clip Health Key News & Latest Developments
Table 98. LumiraDx Company Summary
Table 99. LumiraDx COVID-19 Rapid Antigen Test Kits Product Offerings
Table 100. LumiraDx COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. LumiraDx Key News & Latest Developments
Table 102. Princeton BioMeditech Corporation Company Summary
Table 103. Princeton BioMeditech Corporation COVID-19 Rapid Antigen Test Kits Product Offerings
Table 104. Princeton BioMeditech Corporation COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Princeton BioMeditech Corporation Key News & Latest Developments
Table 106. RapiGEN Inc. Company Summary
Table 107. RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Product Offerings
Table 108. RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 109. RapiGEN Inc. Key News & Latest Developments
Table 110. Orient Gene Company Summary
Table 111. Orient Gene COVID-19 Rapid Antigen Test Kits Product Offerings
Table 112. Orient Gene COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 113. Orient Gene Key News & Latest Developments
Table 114. Wondfo Biotech Company Summary
Table 115. Wondfo Biotech COVID-19 Rapid Antigen Test Kits Product Offerings
Table 116. Wondfo Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 117. Wondfo Biotech Key News & Latest Developments
Table 118. Ihealth (Andon Health) Company Summary
Table 119. Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Product Offerings
Table 120. Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 121. Ihealth (Andon Health) Key News & Latest Developments
Table 122. Wantai BioPharm Company Summary
Table 123. Wantai BioPharm COVID-19 Rapid Antigen Test Kits Product Offerings
Table 124. Wantai BioPharm COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 125. Wantai BioPharm Key News & Latest Developments
Table 126. Biotest Biotech Company Summary
Table 127. Biotest Biotech COVID-19 Rapid Antigen Test Kits Product Offerings
Table 128. Biotest Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 129. Biotest Biotech Key News & Latest Developments
Table 130. Shenzhen YHLO Biotech Company Summary
Table 131. Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Product Offerings
Table 132. Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 133. Shenzhen YHLO Biotech Key News & Latest Developments
Table 134. Vazyme Biotech Company Summary
Table 135. Vazyme Biotech COVID-19 Rapid Antigen Test Kits Product Offerings
Table 136. Vazyme Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 137. Vazyme Biotech Key News & Latest Developments
Table 138. EasyDiagnosis Biomedicine Company Summary
Table 139. EasyDiagnosis Biomedicine COVID-19 Rapid Antigen Test Kits Product Offerings
Table 140. EasyDiagnosis Biomedicine COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 141. EasyDiagnosis Biomedicine Key News & Latest Developments
Table 142. Beijing Hotgen Biotech Company Summary
Table 143. Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Product Offerings
Table 144. Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 145. Beijing Hotgen Biotech Key News & Latest Developments
Table 146. Assure Tech Company Summary
Table 147. Assure Tech COVID-19 Rapid Antigen Test Kits Product Offerings
Table 148. Assure Tech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 149. Assure Tech Key News & Latest Developments
Table 150. Hangzhou AllTest Biotech Company Summary
Table 151. Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Product Offerings
Table 152. Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 153. Hangzhou AllTest Biotech Key News & Latest Developments
Table 154. ACON Biotech Company Summary
Table 155. ACON Biotech COVID-19 Rapid Antigen Test Kits Product Offerings
Table 156. ACON Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 157. ACON Biotech Key News & Latest Developments
Table 158. BGI Genomics Company Summary
Table 159. BGI Genomics COVID-19 Rapid Antigen Test Kits Product Offerings
Table 160. BGI Genomics COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 161. BGI Genomics Key News & Latest Developments
Table 162. Lepu Medical Technology Company Summary
Table 163. Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Product Offerings
Table 164. Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 165. Lepu Medical Technology Key News & Latest Developments
Table 166. Jinwofu Bioengineering Technology Company Summary
Table 167. Jinwofu Bioengineering Technology COVID-19 Rapid Antigen Test Kits Product Offerings
Table 168. Jinwofu Bioengineering Technology COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 169. Jinwofu Bioengineering Technology Key News & Latest Developments
Table 170. Phase Scientific Company Summary
Table 171. Phase Scientific COVID-19 Rapid Antigen Test Kits Product Offerings
Table 172. Phase Scientific COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 173. Phase Scientific Key News & Latest Developments
Table 174. COVID-19 Rapid Antigen Test Kits Capacity of Key Manufacturers in Global Market, 2023-2025 (M Units)
Table 175. Global COVID-19 Rapid Antigen Test Kits Capacity Market Share of Key Manufacturers, 2023-2025
Table 176. Global COVID-19 Rapid Antigen Test Kits Production by Region, 2020-2025 (M Units)
Table 177. Global COVID-19 Rapid Antigen Test Kits Production by Region, 2026-2032 (M Units)
Table 178. COVID-19 Rapid Antigen Test Kits Market Opportunities & Trends in Global Market
Table 179. COVID-19 Rapid Antigen Test Kits Market Drivers in Global Market
Table 180. COVID-19 Rapid Antigen Test Kits Market Restraints in Global Market
Table 181. COVID-19 Rapid Antigen Test Kits Raw Materials
Table 182. COVID-19 Rapid Antigen Test Kits Raw Materials Suppliers in Global Market
Table 183. Typical COVID-19 Rapid Antigen Test Kits Downstream
Table 184. COVID-19 Rapid Antigen Test Kits Downstream Clients in Global Market
Table 185. COVID-19 Rapid Antigen Test Kits Distributors and Sales Agents in Global Market
List of Figures
Figure 1. COVID-19 Rapid Antigen Test Kits Product Picture
Figure 2. COVID-19 Rapid Antigen Test Kits Segment by Type in 2024
Figure 3. COVID-19 Rapid Antigen Test Kits Segment by Application in 2024
Figure 4. Global COVID-19 Rapid Antigen Test Kits Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global COVID-19 Rapid Antigen Test Kits Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global COVID-19 Rapid Antigen Test Kits Revenue: 2020-2032 (US$, Mn)
Figure 8. COVID-19 Rapid Antigen Test Kits Sales in Global Market: 2020-2032 (M Units)
Figure 9. The Top 3 and 5 Players Market Share by COVID-19 Rapid Antigen Test Kits Revenue in 2024
Figure 10. Segment by Type – Global COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global COVID-19 Rapid Antigen Test Kits Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global COVID-19 Rapid Antigen Test Kits Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global COVID-19 Rapid Antigen Test Kits Price (US$/Unit), 2020-2032
Figure 14. Segment by Application – Global COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global COVID-19 Rapid Antigen Test Kits Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global COVID-19 Rapid Antigen Test Kits Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global COVID-19 Rapid Antigen Test Kits Price (US$/Unit), 2020-2032
Figure 18. By Region – Global COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global COVID-19 Rapid Antigen Test Kits Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global COVID-19 Rapid Antigen Test Kits Revenue Market Share, 2020-2032
Figure 21. By Region - Global COVID-19 Rapid Antigen Test Kits Sales Market Share, 2020-2032
Figure 22. By Country - North America COVID-19 Rapid Antigen Test Kits Revenue Market Share, 2020-2032
Figure 23. By Country - North America COVID-19 Rapid Antigen Test Kits Sales Market Share, 2020-2032
Figure 24. United States COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 25. Canada COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe COVID-19 Rapid Antigen Test Kits Revenue Market Share, 2020-2032
Figure 28. By Country - Europe COVID-19 Rapid Antigen Test Kits Sales Market Share, 2020-2032
Figure 29. Germany COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 30. France COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 32. Italy COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 33. Russia COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia COVID-19 Rapid Antigen Test Kits Revenue Market Share, 2020-2032
Figure 37. By Region - Asia COVID-19 Rapid Antigen Test Kits Sales Market Share, 2020-2032
Figure 38. China COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 39. Japan COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 42. India COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America COVID-19 Rapid Antigen Test Kits Revenue Market Share, 2020-2032
Figure 44. By Country - South America COVID-19 Rapid Antigen Test Kits Sales, Market Share, 2020-2032
Figure 45. Brazil COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa COVID-19 Rapid Antigen Test Kits Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales, Market Share, 2020-2032
Figure 49. Turkey COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 50. Israel COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 52. UAE COVID-19 Rapid Antigen Test Kits Revenue, (US$, Mn), 2020-2032
Figure 53. Global COVID-19 Rapid Antigen Test Kits Production Capacity (M Units), 2020-2032
Figure 54. The Percentage of Production COVID-19 Rapid Antigen Test Kits by Region, 2024 VS 2032
Figure 55. COVID-19 Rapid Antigen Test Kits Industry Value Chain
Figure 56. Marketing Channels
